Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
ARKO Petroleum Corp. Fourth Quarter 2025 Earnings Call - IPO Deleveraging and Dealerization Prime M&A Push, 2026 EBITDA Target $156M
ARKO wrapped its first public quarter by using IPO proceeds to cut debt and widen optionality, while leaning into dealerization and fleet fueling to lift margins. Q4 adjusted EBITDA ticked up 4% to $3...
- IPO deployed to strengthen balance sheet and reduce debt, using $206.7 million of net proceeds to pay down liabilities and improve liquidity.
- After IPO adjustments, net debt was ~$319.9 million and net debt to adjusted EBITDA fell to roughly 2.2x, management says it is comfortable with current leverage.
- Q4 2025 adjusted EBITDA was $36.9 million, up about 4% versus Q4 2024; full year adjusted EBITDA was $143.5 million versus $139.2 million in 2024.
- +12 more takeaways
zSpace Q4 & FY2025 Earnings Call - Software mix drove margin expansion while cash fell to $1M and a deep restructuring aims for 2026 breakeven
zSpace closed 2025 with a familiar but ugly combo, top-line pressure and improving unit economics. Revenue fell to $27.9 million for the year, down 27%, and Q4 revenue plunged 43% year-over-year to $4...
- Full-year 2025 revenue was $27.9 million, down 27% year-over-year.
- Q4 2025 revenue declined 43% year-over-year to $4.8 million, affected by a freeze in orders and shipments during the U.S. federal government shutdown.
- Software and services comprised 49% of FY revenue and 57% of Q4 revenue, the fourth quarter mix shift driving meaningful margin improvement.
- +13 more takeaways
Beeline Holdings Q4 2025 Earnings Call - BeelineEquity debuts as capital-light, fee-driven growth engine
Beeline closed 2025 with clear top-line momentum and a strategic pivot. Q4 revenues rose to $2.5 million, up 127% year-over-year, driven by stronger originations, higher revenue per loan and expanded ...
- BeelineEquity launched in Q4 2025 with initial closings alongside partner TYTL, positioned as a capital-light, fee-driven product that does not assume principal risk.
- BeelineEquity fees are 3.5% per transaction for Beeline, plus title revenue, creating a transaction-based revenue stream independent of interest rate spreads.
- Q4 2025 total net revenues were $2.5 million, up 127% year-over-year and up 8.3% sequentially.
- +14 more takeaways
CVD Equipment Corporation Q4 2025 Earnings Call - Sale of SDC to Atlas Copco, cost cuts and outsourcing to shore up the core CVD business
CVD Equipment disclosed a defensive reset. Management is executing a transformation to cut fixed costs, outsource some fabrication, and lean on distributors while selling its SDC business to Atlas Cop...
- CVD entered a definitive agreement to sell its SDC business to Atlas Copco for approximately $16.9 million in cash, subject to adjustments, expected to close in Q2 2026.
- Net cash proceeds from the SDC sale are expected to be approximately $15 million, with about $900,000 held in escrow for post-closing adjustments and indemnities; company intends to invest proceeds initially in U.S. Treasuries.
- The company is executing a transformation plan announced in Q4 to reduce fixed operating costs, transition certain fabrication to outsourced suppliers, and make the organization more agile.
- +12 more takeaways
Solana Company Q4 2025 Earnings Call - Staking Outperformance, 14% SOL-per-Share Gain, and a $526M Warrant Windfall
Solana Company says the post-PIPE pivot to an active digital asset treasury is delivering measurable results. Management highlights staking outperformance versus system averages, strategic partnership...
- Company closed a $500+ million PIPE in September 2025 and says that transaction launched a new, active digital asset treasury strategy.
- Management frames the business around three pillars: capital markets, asset management (core accumulation and staking of SOL), and marketing/partnerships, especially in Asia-Pacific.
- As of December 31, 2025 Solana Company held 2.36 million SOL and $7 million in cash/stablecoins; as of March 27, 2026 the company held 2.33 million SOL.
- +15 more takeaways
Lantern Pharma Q4 2025 Earnings Call - Clinical validation across multiple programs and AI commercialization, but cash runway only into mid‑late 2026
Lantern Pharma used the Q4 2025 call to argue it has moved from hypothesis to clinic. Management highlighted clinical validation across multiple programs: meaningful signals in the LP-300 Harmonic tri...
- Company reports clinical validation across multiple programs: LP-300 Harmonic observations, completed LP-184 Phase I, and an FDA IND cleared for Starlight Therapeutics' pediatric CNS STAR-001 program; management says over 100 patients dosed across programs.
- LP-300 Harmonic trial targets never-smoker NSCLC post-TKI patients; initial safety lead-in showed an 86% clinical benefit rate and 43% objective response rate, including one durable complete response.
- Lantern submitted a Type C meeting package to FDA for LP-300, with the meeting scheduled mid-May 2026, seeking three protocol amendments: focus enrollment on EGFR exon 21 L858R patients, increase maximum cycles from six to eight, and convert to a single-arm Simon’s two-stage design.
- +11 more takeaways
Standard Lithium Ltd. Fourth Quarter 2025 Earnings Call - SWA DFS Clears Path to 2026 FID with Trafigura Offtake and ECA Debt Interest
Standard Lithium used the quarter to tidy up the prerequisites for a final investment decision at its Southwest Arkansas, or SWA, project. The company filed a positive definitive feasibility study for...
- Company filed a positive definitive feasibility study, DFS, for the Southwest Arkansas, or SWA, project showing an initial phase nameplate capacity of 22,500 metric tons per year of battery quality lithium carbonate.
- Smackover Lithium JV filed a maiden inferred resource report for the Franklin Project in East Texas, with management calling it among the highest reported brine lithium grades in North America.
- Standard Lithium received final regulatory approval from the Arkansas Oil and Gas Commission for integration of the Reynolds Brine unit, the planned site for the initial SWA phase.
- +15 more takeaways
Off The Hook Yachts Q4 and Full Year 2025 Earnings Call - $60M Floor Plan and Apex Acquisition to Accelerate Inventory Velocity and Raise 2026 Guidance
Off The Hook reported a strong 2025 marked by record revenue of $119.9 million, 426 boats sold, and an IPO in November that materially strengthened liquidity. Management is betting growth will come fr...
- Record 2025 revenue of $119.9 million, up 21.1% year over year.
- Unit volume hit a record 426 boats, up more than 32% from 2024.
- Company sold 240 company-owned inventory units and transacted 186 brokered deals in 2025.
- +14 more takeaways
Sangamo Therapeutics Q4 2025 Earnings Call - Rolling BLA for ST-920 After Positive STAR Results, Fabry Partnership and Cash Runway Now Central
Sangamo entered 2026 with its lead Fabry program driving the company narrative. Positive registrational STAR results and FDA confirmation that a one-year eGFR slope could support accelerated approval ...
- Sangamo reported positive top-line registrational STAR results for ST-920 in Fabry disease, including a positive mean annualized eGFR slope at 52 weeks across dosed patients, and at two years for 19 patients.
- The FDA reiterated in October 2025 that a one-year eGFR slope could serve as the primary basis for accelerated approval of ST-920, and Sangamo is pursuing that pathway.
- A rolling BLA submission for ST-920 is in progress, with the clinical and nonclinical modules already submitted to the FDA.
- +11 more takeaways
HireQuest, Inc. Fourth Quarter and Year-End 2025 Earnings Call - Divests MRI Permanent Placement, Retains Contract Staffing and Minority Stake
HireQuest reported a down-but-stable 2025, with revenues and system-wide sales sliding from 2024 while adjusted profitability held roughly steady. Management moved decisively on MRI Network, carving o...
- MRI restructuring is the call’s headline action: HireQuest divested the permanent placement/executive search portion of MRI into a new entity led by current and former franchise owners, effective January 1, 2026.
- Post-transaction, HireQuest retains full ownership of MRI’s contract staffing business, and maintains a minority ownership stake plus shared services support for the new MRI entity.
- CFO said the executive search arm generated roughly $65 million of system-wide sales in 2025 and just under $2 million in royalties, and was effectively break-even on an operating basis.
- +13 more takeaways